Clinical Trial Update: Randomized Trial to Assess Efficacy and Safety of Continuous Glucose Monitoring in Children 4-<10 Years With T1DM [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial assessed the efficacy and safety of continuous glucose monitoring in children aged 4 to under 10 with Type 1 diabetes mellitus; resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• continuous glucose monitor (CGM)

Snippet

Sponsor: Jaeb Center for Health Research | Conditions: Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED | Results posted: 2013-12-04